| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9880469dc8f12dad7c3ad95c6ab31fe |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4373927673b3aaa4fc18dd479bf035e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0d5a567874eea0faa0aaa91c56e8274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7160004ab84c7ee6a09c8ae342157895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a863754fb69943fc0a43582facbad77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2896d5f231bdf276ee3907b1ada55da2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_979b338d64e4046bb5cfe82724471052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e76c9519e402a844e2e60ba1132b92b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f499adf20e3c066f8ea448f36a9bd37f |
| publicationDate |
2019-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201902897-A |
| titleOfInvention |
5-5 fused ring as a C5a inhibitor |
| abstract |
The invention especially provides compounds of formula ( I ) Or it is a pharmaceutically acceptable salt of C5a receptor modulator. Pharmaceutical compositions and methods of use are also provided, which include treatment of diseases or conditions involving pathological activation from C5a and non-medical applications. |
| priorityDate |
2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |